Publicaciones en las que colabora con IRENE GUTIÉRREZ CAÑAS (23)

2022

  1. Human CD4+CD45RA+ T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide

    International Journal of Molecular Sciences, Vol. 23, Núm. 4

2021

  1. Proteomic analysis of synovial fibroblasts and articular chondrocytes co-cultures reveals valuable vip-modulated inflammatory and degradative proteins in osteoarthritis

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  2. The neuropeptide vip limits human osteoclastogenesis: Clinical associations with bone metabolism markers in patients with early arthritis

    Biomedicines, Vol. 9, Núm. 12

2020

  1. A clinical approach for the use of VIP axis in inflammatory and autoimmune diseases

    International Journal of Molecular Sciences, Vol. 21, Núm. 1

  2. Comparative Study of Senescent Th Biomarkers in Healthy Donors and Early Arthritis Patients. Analysis of VPAC Receptors and Their Influence

    Cells, Vol. 9, Núm. 12

2019

  1. Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients

    Scientific Reports, Vol. 9, Núm. 1

  2. An Overview of VPAC Receptors in Rheumatoid Arthritis: Biological Role and Clinical Significance

    Frontiers in Endocrinology, Vol. 10

  3. Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin

    Cells, Vol. 9, Núm. 1

2018

  1. The anti-inflammatory mediator, vasoactive intestinal peptide, modulates the differentiation and function of Th subsets in rheumatoid arthritis

    Journal of Immunology Research, Vol. 2018

2016

  1. VIP impairs acquisition of the macrophage proinflammatory polarization profile

    Journal of Leukocyte Biology, Vol. 100, Núm. 6, pp. 1385-1393

2014

  1. VIP modulates IL-22R1 expression and prevents the contribution of rheumatoid synovial fibroblasts to IL-22-mediated joint destruction

    Journal of Molecular Neuroscience, Vol. 52, Núm. 1, pp. 10-17

  2. Vasoactive Intestinal Peptide Maintains the Nonpathogenic Profile of Human Th17-Polarized Cells

    Journal of Molecular Neuroscience, Vol. 54, Núm. 3, pp. 512-525

2013

  1. IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts

    Rheumatology (United Kingdom), Vol. 52, Núm. 12, pp. 2177-2186

2012

  1. Effect of VIP on the balance between cytokines and master regulators of activated helper T cells

    Immunology and Cell Biology, Vol. 90, Núm. 2, pp. 178-186

2010

  1. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes

    Immunology and Cell Biology, Vol. 88, Núm. 7, pp. 734-745

  2. Peptides targeting toll-like receptor signalling pathways for novel immune therapeutics

    Current Pharmaceutical Design, Vol. 16, Núm. 9, pp. 1063-1080

2008

  1. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: Implications for rheumatoid arthritis

    Brain, Behavior, and Immunity, Vol. 22, Núm. 3, pp. 312-317

  2. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts

    Molecular Immunology, Vol. 45, Núm. 11, pp. 3065-3073

2007

  1. Regulation of TLR expression, a new perspective for the role of VIP in immunity

    Peptides, Vol. 28, Núm. 9, pp. 1825-1832

2006

  1. VIP decreases TLR4 expression induced by LPS and TNF-α treatment in human synovial fibroblasts

    Annals of the New York Academy of Sciences